Selinexor,ruxolitinib
karyopharm therapeutics,novartis,incyte
['ruxolitinib', 'rux,(-crux),(-trux)', 'rux,(-crux),(-trux),(-deruxtecan)', 'selinexor']
join us for our investor call where we will discuss the updated data on selinexor in combination with ruxolitinib, the current treatment landscape and unmet medical need in treating patients with myelofibrosis. learn more here: #aacr23 
Karyopharm Therapeutics Inc. is an oncology-focused biopharmaceutical company focused on the discovery, development and commercialization of novel medicines.